YERVOY® Risk Minimization Tool Effectiveness Evaluation Survey
NCT02224768
·
clinicaltrials.gov ↗
COMPLETED
Status
158
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Melanoma
Interventions
DRUG:
Ipilimumab
Sponsor
Bristol-Myers Squibb